Manager TitleAgeSince
Chief Executive Officer 49 31/05/2025
Director of Finance/CFO 61 31/05/2025
Sales & Marketing 53 01/01/2024
Director TitleAgeSince
Director/Board Member 62 01/01/2020
Chairman 42 01/06/2025
Director/Board Member 75 01/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+2.29%+2.36%-17.97%-10.09% 180B
+1.46%+0.01%-9.87%-6.25% 107B
+1.58%+0.65%+6.69%+61.86% 60.29B
-1.13%-2.60%+26.37%+54.76% 50.19B
+2.22%-1.14%-14.85%-44.15% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-17.52%-43.99% 27.61B
-7.67%-8.39%+17.59%-12.73% 23.1B
+1.63%-1.73%-5.80%-7.80% 20.86B
Average -3.03%-2.24%-1.92%-1.05% 60.44B
Weighted average by Cap. +1.28%-0.40%-6.63%+0.84%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock